attivita` scientifica e pubblicazioni

PUBBLICAZIONI DOTT. LAZZARONI
ANNO 1975
1) BianchiPorro G, Lazzaroni M, Petrillo M: La cirrhose du foie ascitogene. Action de l'amiloride sur
le metabolism hydroelectrolitique.
La nouv Pres Med 14,1043
2) BianchiPorro G, Lazzaroni M, Petrillo M et al. L'amiloride un nuovo diuretico risparmiatore di
potassio nel trattamento della cirrosi epatica ascitogena
Il Fegato 21, 313-316
3) BianchiPorro G, Ferrara A, Lazzaroni M et al Attività della tritiozina (ISF 2001) sull.a secrezione
gastrica notturna. Studio cross-over doppio cieco
Minerva Gastroenterologica 1975,23,22-25
4) BianchiPorro G, Ferrara A, Lazzaroni M et al: Effetti della tritiozina sulla secrezione acida
notturna nell'uomo.
Da La ricerca scientifica nell'industria farmaceutica In Italia
Ferro ed. 833-837,1975
ANNO 1977
5) Bevilacqua M, Lazzaroni M, Giovannetti G et al : Il comportamento della frazione libera
dell'aldosterone plasmatico nella cirrosi epatica. Da: Le malformazioni delle vie biliari
CEPI ed, 225-230
6) Lazzaroni M, Benassai D, Bosisio E et al: Confronto tra amiloride e spironolattone quali
risparmiatori di potassio nel trattamento dell'ascite da cirrosi epatica.
Da: Le malformazioni delle vie biliari CEPI ed, 231-240
ANNO 1978
7) Petrillo M, Lazzaroni M, Prada A et al: Farmaci antiflogistici e stomaco
Boll AIGO, suppl 4, 443-448
ANNO 1979
8) Petrillo M, Caruso I, Fumagalli M, Montrone F, Lazzaroni M: Diflunisal, aspirin anfd gastric
mucosa
Lancet 1979, 2, 638
9) Petrillo M, Benassai D, Lazzaroni M et al: Cimetidine in long term treatmenty of recurrent peptic
ulcer disease.
Drug Exptl Clin Res, 107-111
10) BianchiPorro G, Petrillo M, Lazzaroni M et al: Pirenzepine versus cimetidine in the treatment of
duodenal ulcer
Scand J gastroenterol 14, suppl 57,41-45
11) Lazzaroni M, Grossi E, Petrillo M et al: L'impiego della bumetanide nella cirrosi epatica
ascitogena. Confronto con la furosemide
Farmaci, 3, suppl 3,33-38
ANNO 1980
12) Petrillo M, Lazzaroni M, Saponati G et al: The use of rociverine as premedication for endoscopy
of the upper gastrointestinal tract: a double blind controlle d clinicalò trial
Curr Med Res Opin 1980,7,73-77
13) Grossi E, Lazzaroni M, Miglioli G: Il carbenoxolone: farmacocinetica e farmacologia clinica. In:
La malattia peptica. Barbara G, BianchiPorro G eds, 1980, 135
14) BianchiPorro G, Petrillo M, Grossi E, Lazzaroni M: Smoking and duodenal ulcer
Gastroenterology 1980,78,180
15) Petrillo M, Lazzaaroni M, Prada A et al: Oxmetidina vs cimetidina nel trattamento dell'ulcera
duodenale.
Ital J gastroenterol 12, suppl 52
16) Grossi E, Petrillo M, Lazzaroni M et al: La titolazione intragstrica, perfezionamento del metodo
e risultyati preliminari
Ibidem
17) Lazzaroni M, Petrillo M, Prada A: Effetto del fumo sulla recidiva ulcerosa in corso di terapia di
mantenimento in pazienti portatori di ulcera duodenale
Ibidem
ANNO 1981
18) Lazzaroni M, Petrillo M, DElla Vedova G et al: L'acido tienilico nel trattamento della cirrosi
epatica ascitogena
L'Ospedale Maggiore 1981, 76,152
19) BianchiPorro G, Petrillo M, Lazzaroni M et al: Healing of duodenal ulcer with twice daily
oxmetidine
In: Cimetidine in the 80s, Baron JH ed, Churchill Livingstone 27
20) Lazzaroni M, Petrillo M, BianchiPorro G et al: Trattamento a lungo termine con amiloride ed
idroclorotiazide in pazienti con cirrosi epatica ascitogena
Epatologia 1981, 27,57
21) BianchiPorro G, Lazzaroni M, pEtrillo M: Carcinoma gastrico ed endoscopia digestiva alta.
Atti ( giornate di Gastroenterologia medica e chirurgica Ospedale S carlo, Milano
Il pensiero Scientifico 1981, 60
22) BianchiPorro G, Prada A, Lazzaroni M: Women and duodenal ulcer.
Brit Med J:283,235
23) BianchiPorro G, Prada A, Parente F, Sangaletti O, Lazzaroni M: The effect of pirenzepine on
meal stimulated gastric acid secretion, gastrin release and gastric emptying
Scand J Gastroenterol 1981, 17, suppl 72,159
24) BianchiPorro G, PetrilloM, Lazzaroni M: ranitidine in the short term treatment of duodenal
ulcer; a multicentre endoscopic double blind trial. In: The clinical use of ranitidine, Medicine
Publishing Foundation, 1981, 136
25) BianchiPorro G, Prada A, Petrillo M, Lazzaroni M: gastric acid secretion, smoke and duodenal
ulcer healing
Gastroenterology 1981,82;394
ANNO 1982
26) DalMonte PR, D'Imperio N, Giuliani Piccari G, Lazzaroni M et al: Pirenzepine for short and long
term treatment of duodenal ulcer. In: Peptic ulcer disease: advances in pathogenesis and
treatmemt. BianchiPorro G, Bardhan KD eds, Cortina, 1982, 137
27) BianchiPOrro G, Petrillo M, Lazzaroni M et al: The longer term treatment of duodenal ulceration
with cimetidine
Ibidem, 1982, 107
28) BianchiPorro G, Lazzaroni M, Petrillo M: Gastroscopy on elderly patients
Curr Med Res Op 1982,7,96
29) Bianchiporro G, Lazzaroni M: Analysis of costs benefits in gastroenterology. In: Progress in
Clinical Pharmacy, Ostino G, Martini N, Van der Klejin eds, Elsevier Biomedical Press, 1982,27
30) BianchiPorro G, Lazzaroni M, Guidi G: Influenza di recenti progressi terapeutici sull'evoluzione
della malattia ulcerosa.
Farmaci 6, suppl 1, 51
31) BianchiPorro G, Lazzaroni M, Petrillo M et al: Il carcinoma del moncone gastrico.
Rec Progr Med 1982,72,159
32) Lazzaroni M, BianchiPorro G: Recenti acquisizioni in tema di fisiopatogenese e diagnosi delle
diarree
Rec Prog Med 1982, 72,71
33) Petrillo M, Lazzaroni M, Prada A et al: A controlled trial of pirenzepin versus carbenoxolone in
the treatment of gatsric ulcer. In: Advances in gastroenterology with the selective antimuscarinic
compound pirenzepine. Excerpta Medica, 1982, 205
34) Lazzaroni M, Petrillo M, Prada A et al: Secrezione acida gastrica e rischio di recidiva in corso di
trattamento a luingo termine con cimetidina
Boll AIGO suppl 1982, 5, 213
35) Prada A, Lazzaroni M, Petrillo M et al: Effetto della ranitidina sulla secrezione acida gastrica
nell'uomo
Boll AIGO 1982,suppl 5,219
36) Petrillo M, Lazzaroni M, Parente F et al: Terapia a lungo termine continuativa ( 3 anni) con
cimetidina nell'ulcera duodenale. Risultati preliminari
Boll AIGO, 1982,suppl 5, 219
37) BianchiPorro G, Petrillo M, Lazzaroni M et al: Ranitidine in the treatment of gastric lesions
induced antiinflammatory drugs
Hepato-gastroenterology 1982, 29,86
38) BianchiPorro G, lazzaroni M: I farmaci per le malattie infiammatorie. farmacologia clinica e
principi di terapia
Atti IX giornate Di gastroeneterologia Ospe S Carlo Borromeo, Milano, 1982, 93
ANNO 1983
38) BianchiPorro G, Lazzaroni M, Petrillo M: Rising female predominance in incidence of gastric
ulcer
Brit Med J 1983, 286,393
40) Petrillo M, Lazzaroni M, DeNicola C et al: Impiego della ranitidina nella terapia delle lesioni
gastriche e duodenali secondarie a farmaci antiglogistici. Risultati preliminari.
In: ranitidina il nuovo H2 antagonista. Barbara L, Dobrilla G eds, Libreria Cortina, Verona,
1983,169
41) Mazzacca G, Sabbatini F, Barbara L, Miglioli G, BianchiPorro G, Lazzaroni M et al: Trattamento
dell'ulcera duodenale con ranitidina: studio a lungo termine.
In: ranitidina il nuovo H2 antagonista. Barbara L, Dobrilla G eds, Libreri Cortina, Verona, 1983, 183
42) BianchiPorro,G, Prada A, Lazzaroni M et al: Smoking and gastric inhibition by H2 antagonists
Lancet 1983,1,584
43) BianchiPorro G, lazzaroni M, Lodola E: Blood levels of cimetidine in patients with liver cirrhosis
Intern J Clin Pharmac Ther Toxic 21,374
44) BianchiPorro G, Lazzaroni M, Petrillo M: Gastric carcinoma and duodenal ulcer
Amer J gastroenterol 78,463
45) Albano O, Barbara L, Bianchiporro G, Biasco G, Borgonovi E, Cheli R, Circella A, Dallamano R,
Lazzaroni M et al: Scelte organizzative e modelli di assistenza: il caso del day hospital. In L'analisi
costi benefici, F Angeli ed, Milano, 65
46) Parente F, Sangaletti O, DellaVEdova G, Lazzaroni M et al: La misurazione dell'H2 espirato: un
metodo indiretto nella diagnosi del malassorbimento di lattosio
Clinica E laboratorio 7,171-179
47) Lazzaroni M, Petrillo M,, DeNicola G et al: DeNol liquid and cimetidine twice daily in the
treatment of duodenal ulcer. A preliminary study
Brit J Clin Pract 1983, 37,71
48) BianchiPorro G, Lazzaroni M, Petrillo M: Effect of cimetdine on surgery for duodenal ulcer in
Italy
Ital J gastroenterol 15,274
49)BianchiPorro G, Lazzaroni M: Critical notes on recent progress in gastroenterology
Medicina 1983, 3,173
50) BianchiPorro G, Lazzaroni M, Petrillo M: Il valore dell'endoscopia nella diagnosi di linfoma
primitivo gastrico. Atti 6 Congresso Collegium Internationale Chirurgiae Digestivae,
Maraffetti e Pollini ed, 377
51) Lazzaroni M, BianchiPorro G: Gli ormoni gastroenterici nella diagnostica funzionale del
pancreas
Atti 10 giornate di Gastroenterologia medica e chirurgica Ospedale S carlo, Milano, Libreria
Scientifica
ANNO 1984
52) BianchiPorro G, Lazzaroni M, Petrillo M et al: Relapse rates in duodenal ulcer patients formerly
treated with bismuth subcitrate or maintained with cimetidine. Lancet 1984, 2,698
53) BianchiPorro G, Grossi E, Sangaletti O, Lazzaroni M et al: Gli antiacidi. In: I farmaci delle
malattie gastroenteriche. BianchiPorro G, Tognoni G eds, Il Pensiero Scientifico, Roma, 38, 1984
54) Lazzaroni M, Prada A, BianchiPorro G: Gli anticolinergici. In.I farmaci delle malattie
gastroenteriche.BianchiPorro G, Tognoni G eds, Il pesnsiero Scientifico, Roma, 67, 1984
55) BianchiPorro G, Lazzaroni M, Petrillo M: Gli antagonisti dei recettori H2 gastrici ( cimetidina e
ranitidina)
In.I farmaci delle malattie gastroenteriche.
BianchiPorro G, Tognoni G eds, Il pesnsiero Scientifico, Roma, 92, 1984
56) BianchiPorro G, Lazzaroni M, Parente F: I farmaci della barriera mucosa. In.I farmaci delle
malattie gastroenteriche. BianchiPorro G, Tognoni G eds, Il pesnsiero Scientifico, Roma, 150,1984
57) Lazzaroni M, BianchiPorro G: I più recenti antiulcera.
In.I farmaci delle malattie gastroenteriche.
BianchiPorro G, Tognoni G eds, Il pesnsiero Scientifico, Roma, 191,1984
58) Petrillo M, Lazzaroni M, BianchiPorro G: Gli antiodiarroici In.I farmaci delle malattie
gastroenteriche.
BianchiPorro G, Tognoni G eds, Il pesnsiero Scientifico, Roma, 315,1984
59) Petrillo M, Lazzaroni M, BianchiPorro G: I lassativi
In.I farmaci delle malattie gastroenteriche.
BianchiPorro G, Tognoni G eds, Il pesnsiero Scientifico, Roma, 308, 1984
60) BianchiPorro G, Lazzaroni M, Sangaletti O: Effects of nifedipine on gastric acid secretion and
gastrin release in man
Ital J gastroenterol 16,56
61) BianchiPorro G, Petrillo M, DeNicola C, Lazzaroni M: A double blind endoscopic study with
DeNol tablets and cimetdine for duodenal ulcer Scand J gastroenterol 1984, 19,905
62) BianchiPorro G, Lazzaroni M: Pancreatiti croniche
Enciclopedia Medica Italiana, USES, 11,892,1984
63) DalMonte PR, Giuliani Piccari G, D'Imperio N, BianchiPorro G, Lazzaroni M et al: Pirenzepine for
the treatment of non ulcer dyspepsia: results of a double blind multicentre trial
Symposium Pirenzepine: new aspects in research and therapy
Lisbon, 93
64) Pace F, Lazzaroni M, BianchiPorro G: La pHmetria esofagea
Notiziario Chirurgico 5,255
65) Lazzaroni M: Storia naturale dell'ulcera duodenale silente
Atti VI giornate gastroenterologiche Osped L sacco, 1984,27
66) Bianchi Porro G, Lazzaroni M, Petrillo M: Giant duodenal ulcers
Am J gastroenterol 1984,29:781
ANNO 1985
67) Parente F, Imbimbo B, Lazzaroni M et al: The use of cimetropii bromide as premedication for
endoscopy of the upper gastrointestinal tract: a double blind controlled study
I Intern Med Res 13,332
68) Lazzaroni M, Parente F, Mailland F et al: Timepidium bromide as premedication before
duodenoscopy
Curr Ther Res 37,277
69) BianchiPorro G, Lazzaroni M: Tre nuovi farmaci antulcera: omeprazolo, famotidina, bismuto
colloidale. Esperienze preliminari. International Symposium: New Trends in ulcer disease:
heterogeneity subclinical markers, treatment
Padova, 27 settembre,1985
70) Lazzaroni M, Sangaletti O, Del Soldato P et al: Effect of pirenzepine and atropine on peptone
meal stimulated gastric secretion and plasma gastrin in healthy volunteers, patients with duodenal
ulcer and vagotomized patients
Digestion 32,267
71) BianchiPorro G, Lazzaroni M, Grossi E et al: Effect of maprotiline on pentagastrin stimulated
acid secretion in man
Scand J gastroenterol 20,912
72) Parente F, lazzaroni M, Sangaletti O et al: Cigarette smoking, gastric acid secretion and serum
pepsinogen 1 concentrations in duodenal ulcer patients
Gut 26,1327
73) Paoluzi P, Torsoli A, BianchiPorro G, Lazzaroni M et al: Famotidine in the treatment of gastric
ulcer. Results of a multicentre double blind controlled trial
Digestion 32, suppl 1,38,1985
74) Barbara L, Corinaldesi R, BianchiPorro G, Lazzaroni M et al: Famotidine in the management of
duodenal ulcer. Experience in Italy
Digestion 32, suppl 1, 24,1985
75) BianchiPorro G, Petrillo M; Lazzaroni M et al: Comparison of pirenzepine and carbenoxolone in
the treatment of chronic gastric ulcer: A double blind endoscopic trial
Hepatogastroenterology, 32, 283
ANNO 1986
76) BianchiPorro G, Dal Monte PR, Lazzaroni M et al: Pirenzepine and ranitidine for crhonic gastric
ulcer: a comparison in short term and maintenance treatment
Curr Ther Res 1986, 39,149
77) BianchiPorro G, parente F, Lazzaroni M et al: Medium dose antacids versus cimetidine in the
short term treatment of dudoenal ulcer
J Clin Gastroenterol 1986,8,141
78) Lazzaroni M, Parente F, Prada A et al: Colloidal bismuth subcitrate as coated tablets: four
times versus twice daily dosage in duodenal ulcer
Scand J gastroenterol 21, suppl 122, 51
79) BianchiPorro G, Parente F, Lazzaroni M et al: Colloidal bismuth subcitrate and two different
dosages of cimetidine in the treatment of resistant duodenal ulcer
Scand J Gastroenterol 21, suppl 122,39
80) Antonioli A, Gandolfo M, Rigo GP, BianchiPorro G, Cheli R, Brancato F. Lazzaroni M et al:
Somatostatin and cimetidine in the control of acute upper gastrointestinal bleeding. A controlled
multicenter study
Hepatogastroenterology 33,71
81) Lazzaroni M, Petrillo M, Sangaletti O et al : Effect of nifedipine on gastric acid secretion and
gastrin release in man
Hepatogastroenterology 33,257
82) BianchiPOrro G, Lazzaroni M, Parente F et al: Th einfluence of colloidal bismuth subcitrate on
duodenal ulcer relapse
Scand J gastroenterol, 21, suppl 122,35
83) Parente F,Lazzaroni M, Petrillo M et al: Colloidal bismuth subcitrate and ranitidine in the short
term treatment of benign gastric ulcer
Scand J Gastroenterol 21, suppl 122, 42
84) Lazzaroni M, Sangaletti O, Parente F BianchiPorro G:
Inhibition of food stimulated acid secretion by
association of pirenzepine and ranitidine in duodenal ulcer
patients.
Int J Clin Phar. Ther. Toxicol., 24,685-688,1986
85) BianchiPorro G, Lazzaroni M, Pace F
Long-term low dose antacid versus cimetidine therapy in the
treatment of duodenal ulcer recurrence.
Scand J gastroenterol., 21,1144-1146,1986.
86) BianchiPorro G., Lazzaroni M.: Colloidal bismuth subcitrate.
Medicina, 6,415-417,1986.
87) Bardhan KD, BianchiPOrro G, Bose K, Daly M, Hinchliffe RFC, Jonsson E, Lazzaroni M et al: A
comparison of two different doses of omeprazole versus ranitidine in treatment of duodenal ulcers.
J Clin Gastroenterol 8:408-413
88) BianchiPoro G., Lazzaroni M., Parente F.: Ranitidina,
cimetidina, famotidina.
Estratto dal volume 13 Enciclopedia Medica Italiana,
Uses Edizioni,130/150,1986
89)Lazzaroni M, parente F, petrillo M. Progressi in terapia antiulcera.
In: New Trends in Ulcer disease. Di Mario, Battaglia, Vianello eds Piccin, 237-246
90) Parente f, Baroni S, Lazzaroni M: Influenza del fumo di sigaretta sulla terapia acuta e di
mantenimento dell'ulcera duodenale
In: New Trends in Ulcer disease. Di Mario, Battaglia, Vianello eds Piccin, 153-161
ANNO 1987
91) BianchiPorro G., Lazzaroni M., Parente F.:The use of
antimuscarinic drugs in upper gastrointestinal tract endoscopy.
Am J gastroenterol., 82,916,1987
92) Parente F., Lazzaroni M., Panza E.,Ardizzone A.,
BianchiPorro G.: Sucralfate in the treatment of duodenal ulcer. A double blind endoscopic
controlled short-term study versus placebo.
In: Topics in peptic ulcer disease. Bianchi Porro G., Bardhan KD eds., Cortina International,
1987,169-174.
93)BianchiPorro G., Lazzaroni M., Parente F., Petrillo M.:
Medical treatment of duodenal ulcer. Presente status.
In: Topics in pepticulcer disease. BianchiPorro G., Bardhan KD eds .Cortina International,3568,1987.
94)BianchiPorro G., Lazzaroni M., Pagliaro L et al.:
Maintenance treatment with cimetdine in peptic ulcer disease for up to 3 years. Experience in Italy.
In: Topics in peptic ulcer disease. BianchiPorro G., Bardhan KD eds. Cortina International,175180,1987.
95) Lazzaroni M., Sangaletti O., Ghirardosi C., ArdizzoneS.,
BianchiPorro G.: Effect of esaprazole on sham-feeding stimulated
and pentagastrin stimulated acid secretion in humans.
Curr Ther Res., 41,290-297,1987.
96) BianchiPorro G, Parente F., Lazzaroni M.:Tripotassium
dicitrato bismuthate (TDB) versus two different dosages of
cimetidine in the treatment of resistant duodenal ulcers.
Gut, 28,907-911,1987.
97)BianchiPorro G., Lazzaroni M., Cortvriend WRE.: Maintenance
therapy with colloidal bismuth subcitrate in duodenal ulcer
disease. Digestion,37, suppl 2,47-52,1987.
98) Petrillo M., lazzaroni M., Fuccella L., Sassella D.,
BianchiPorro G.: Gastric antisecretory and cytoprotective
activity of MDL 646. A 16 Methyl-16 methoxy prostaglandin E1
analog in man. Hepato-gastroenterol., 34,117-119,1987.
99) BianchiPorro G.,Lazzaroni M., Imbimbo B et al.: Action of
mifentidine on the secretory response to sham feeding and
pentagastrin and on serum gastrin in duodenal ulcer patients.
Eur J Clin Pharmacol., 32,555-558,1987.
100) Lazzaroni M., Ardizzone S., Imbimbo B., Sangaletti O.,
Ghirardosi C., BianchiPorro G.: Effect of mifentidine, a new
H2 antagonist on pentagastrin stimulated acid secretion in
healthy subjects.
Inter J Clin Pharmacol. Ther. Toxicol.,25, 218-221,1987.
101)BianchiPorro G., Lazzaroni M.: Famotidina.
Medicina.,7,241-243,1987.
102) Lazzaroni M.,Sangaletti O., BianchiPorro G.: Effect of
cisapride on gastric emptying and ileal transit time of balanced
liquid meal in healthy subjiects.Digestion,110-113,1987.
103) BianchiPorro G, Pace F, lazzaroni M: Esophagitis healing
with ranitidine Gastroenterology 92,2051-2052
ANNO 1988
104) BianchiPorro G., Lazzaroni M.: Terapia di mantenimento
dell'ulcera peptica.
Gastroenterologia Clinica, 17,1-15,1988
105) BianchiPorro G., Imbimbo B., Lazzaroni M.: Effect of
mifentidine on peptone meal-stimulated gasric acid secretion and
plasma gastrin levels in duodenal ulcer patients.
Agents and Action,25, 22-26,1988.
106) Lazzaroni M.: Studio multicentrico sull'efficacia del CBS
bid nella terapia dell'ulcera peptica.
Nuovi Argomenti Medicina., 4,331-333,1988.
107) Lazzaroni M., Parente F., petrillo M., BianchiPorro G.:
Confronto tra bismuto colloidale (DeNol) bid e qid nella
terapia a breve termine dell'ulcera duodenale.
Argomenti gastroenterologia Clinica., 1,37-41,1988.
108) BianchiPorro G., lazzaroni M., Barbara L. et al.:
Tripotassium dicitrate bismuthate and ranitidine in duodenal
ulcer. Scand J Gastroenterol., 1988,23,1232-1236
109) BianchiPorro G, lazzaroni M: Terapia a lungo termine
dell'ulcera peptica.Jama, 5, suppl 7,1-8
110) Lazzaroni M, Imbimbo B, Sangaletti O: gastric acid and
pepsin secretion after single oral doses of mifentidine in healthy
subjects. Scand J gastroenterol,23,788-792
111) BianchiPorro G, Baroni S, Parente F, Lazzaroni M: midazolam
versus diazepam as premedication for upper gastrointestinal
endoscopy: a randomized, doubleblind, cross-over study.
Gastrointest Endosc,34,252-254
112) BianchiPorro G, Lazzaroni M: Clinica e terapia della
sindrome dell'intestino irritabile. Il Polso,8/9, supplemento,
113) BianchiPorro G, Lazzaroni M: Campylobacter pylori and ulcer recurrence
Lancet 1,593,1988
ANNO 1989
114) BianchiPorro G., Lazzaroni M: Helicobacter pylori, luci ed ombre
Atti del XXVII Congresso Nazionale SIGE, Monguzzi ed., 29-39
115) Bianchi Porro G, Lazzaroni M: Sucralfate: a new broad
spectrum antiulcer drug ?. In: Treatment of digestive disease with sucralfate.
BianchiPorro G., Hollander D eds, Cortina International, 13-6
116) BianchiPorro G., lazzaroni M et al: famotidina o ranitidina
nella profilassi della recidiva dell'ulcera duodenale.
Arg Gastroenterol Clin, 2, 105-114
117) BianchiPorro G, Lazzaroni M: Ruolo della dieta in
gastroenterologia.
Acta medica, 27,221-233
118) Lazzaroni M., Bianchi Porro G: Campylobacter pylori
epatologia della mucosa gastroduodenale: revisione critica dei
contributi clinico-sperimentali e terapeutici.
Medicina, 9,9-18
119) Lazzaroni M., BianchiPorro G: The effect of an oral morning
dose of nizatidine and ranitidine on gastric acid secretion in
duodenal ulcer patients.
Hepato-gastroenterolol,36,490-493
120) BianchiPorro G, Lazzaroni M, battocchia A: Ulcera
gastroduodenale.
Enciclopedia Medica Italiana, 15, 961-1000
121) BianchiPorro G., Lazzaroni M: Campylobacter pylori and
peptic ulcer therapy
Gastroenterol Clin Biol, 13,107-111
122) Lazzaroni M, Petrillo M, BianchiPorro G: comparison of qid andbid administration of DeNol in
the short term treatment of duodenal ulcer.
Brit J Clin Pract, 43,1-5
123) BianchiPorro G, lazzaroni M.: H2 blockers
Adis Press,1990, 1-8
ANNO 1990
124) BianchiPorro G, Lazzaroni M et al: Combined ranitidine and
pirenzepine in the treatment of duodenal ulcer: a multicentre
double blind study using endoscopy
J Intern Med Res, 18,341-350
125) Lazzaroni M, Grossi E, BianchiPorro G: The effect of
intravenous doxofylline or aminophylline on gastric secretion
in duodenal ulcer patients
Aliment Pharmacol therap, 4,643-649
126) Sabbatini F, Lazzaroni M, Petrillo M et al: comparative
study of mifentedine and ranitidine in the short term treatment
of duodenal ulcer
Eur J Clin Pharmacol, 39,515-517
127) Euler Ar, Krawiec J, Odes H,Gilat T, Garcia L, Rachmilewitz D Dabryelewicz A, Gibinski K, Bass
D, Barbara L, BianchiPorro G,
LAZZARONI M et al:An evaluation of Arbaprostil at multiple
doses for the treatment of acute duodenal ulcer: a randomized
double blind placebo controlled international trial.
Am J gastroenterol, 85, 145-149
ANNO 1991
128) BianchiPorro G, Lazzaroni M: Premedication for upper
gastrointestinal endoscopy: still a matter for debate ?
Endoscopy,23,32-36
129) BianchiPorro G., lazzaroni M, Barbara L et al: famotidine
vs ranitidine hs in acute duodenal ulcer. A multicentre endoscopic
trial.
It J Gastroenterol., 23,65-69
130) BianchiPorro G, Lazzaroni M., Barbara L et al: A controlled
study of 20 mg famotidine nocte vs 150 mg ranitidine nocte for the
prevention of duodenal ulcer relapse.
Aliment Pharmacol therap, 5,181-189
131) Pace F., Lazzaroni M, BianchiPorro g: failure of sucralfate
in the treatment of refractory esophagitis versus high dose
famotidine
Scand J gastroenterol, 26,491-494
132) D'Adda T, Pilato F, Lazzaroni M et al: Ultrastructural
morphometry of gastric endocrine cells before and after
omeprazole.A study in the oxyntic mucosa of duodenal ulcer
patients.
gastroenterology, 100,1563-1570
133) Bardhan KD, Naesdal J, BianchiPorro G, Lazzaroni M et al:
treatment of refractory peptic ulcer with omeprazole or
continued H2 receptor antagonists:a controlled clinical trial
Gut, 32, 435-438
134) BianchiPorro G, Lazzaroni M: long term treatment of duodenal
ulcer with colloidal bismuth subcitrate: a double blind,
placebo controlled study.
Eur J Gastroenterol Hepatol, 3,223-228
135) BianchiPorro G, Lazzaroni M: Colloidal bismuth subcitrate
In: Ulcer disease. Investigation and basis for therapy. EA Swabb, S Szabo eds, Dekker ,287-321
136) BianchiPOrro G, Lazzaroni M, Parente F et al: Diazelmus versus diazepam as premeducation
in upper gastrointestinal endoscopy: a randomized cross-over study
Endoscopy 23;203-205
137) BianchiPorro G, Lazzaroni M: Utilità della eradicazione dell'helicobacter pylori nei soggetti con
ulcera duodenale
In: Ruolo dell'Helicobacter pylori nelle malattie gastroduodenali. Barbara L, Biasco G, Corinaldesi R,
DiFebo G, Miglioli M, Vaira D eds, Themes editore, 163-176
138) Lazzaroni M, Parente F, BianchiPorro G: L'inibizione della secrezione acida nel trattamento
dell'ulcera peptica: come quando e perchè. In: Terapia dell'ulcera peptica negli anni 90; tempo di
bilanci. BianchiPorro G, Lazzaroni M eds, Cortina International, 9-24
139) Lazzaroni M, BianchiPorro G: Il paziente ulceroso resistente
In: Terapia dell'ulcera peptica negli anni 90; tempo di bilanci. BianchiPorro G, Lazzaroni M eds,
Cortina International, 101-114
140) BianchiPorro G, Lazzaroni M: Ulcera peptica cronica: strategie terapeutiche attuali.
In: Terapia dell'ulcera peptica negli anni 90; tempo di bilanci. BianchiPorro G, Lazzaroni M eds,
Cortina International, 143-172
141) BianchiPorro G, Lazzaroni M: Omeprazolo
Enciclopedia Medica Italiana, Uses ed, 1991, 5520-24
142) BianchiPorro G, lazzaroni M. Nizatidina
Enciclopedia medica Italiana, Uses ed, 1991,5454-5456
ANNO 1992
143) BianchiPorro G, parente F, Lazzaroni M , Petrillo M: Enprostil vs ranitidine in the short term
treatment of benign gastric ulcer
A double blind placebo controlled trial
Drug Invest 4:143-148
144) Lazzaroni M, Sangaletti O, BianchiPorro G: Gastric acid secretion and plasma gastrin during
short term treatment with omeprazole and ranitidine in duodenal ulcer patients
Hepato-gastroenterol 39:366-370
145) D'Adda T, Bordi C, Lazzaroni M, BianchiPorro G: Long term omeprazole monotherapy is
ineffective against helicobacter pylori infection
Am J Gastroenterol ,87, 681 letter
146) Negrini R, Zanella I, Savio A, Poiesi C, Verardi R, Ghielmi S, Albertini A, Sangaletti O,
LAZZARONI m, BianchiPorro G: Serodiagnosis of helicobacter pylori associated gastritis with a
compeptitive enzyme linked immunoadsorbent assay
Scand J Gastroenterol 27:599-605
147) Lazzaroni M, Sangaletti O, BianchiPorro G: The effect of a single oral morning dose of
nizatidine and ranitidine on intragastric pH under basal conditions and after pentagastrin
stimulation
J Intern Med Res 20:454-460
148) BianchiPorro G, Lazzaroni M: Peptic ulcer disease: medical treatment. In: The stomach.
Gustavvson S, Kumar D, Graham DY eds, Churchill Livingstone, London 246-265
149) BianchiPorro G, Lazzaroni M: Preparation, premedication surveillance
Endoscopy,1992,24:1-8
150) BianchiPorro G, lazzaroni M, Scarpignato C: Roxatidina acetato, un nuovo H2 antagonista
Argomenti Gastroenterol Clin 1992,5:347-359
151) M Lazzaroni e Gruppo di Studio gastrolink: Ulcera peptica in Italia: caratteristiche clinico
epidemiologiche
Argomenti Gastroenterol Clin 1992:5:385-391
152) Lazzaroni M, BianchiPorro G: i radionuclidi nella diagnostica dell'apparato digerente
Diagnosis 1992,4:33-37
ANNO 1993
153) BianchiPorro G, Parente F, Lazzaroni M: Short and long term outcome of Helicobacter pylori
positive resistant duodenal ulcers treated with colloidal bismuth subcitrate plus antibiotics or
sucralphate alone
Gut, 34:466-469
154) BianchiPorro G, Lazzaroni M: Prevention and treatment of non steroidal gastrointestinal
lesions
Europ J Gastroenterol Hepatol 5: 420-432
155) BianchiPorro G, Lazzaroni M: Prescribing policy for antiulcer treatment in the elderly
Drugs-Aging 1993,3:308-319
156) Lazzaroni M, Imbimbo B, Bargiggia S et al: Effects of magnesium aluminum idroxide antacid
on absorption of rufloxacin
Antimicrob Agents Chemother, 1993,37,2212-2216
157) Lazzaroni M, BianchiPorro G: The relationship between duodenal ulcer disease and
Helicobacter pylori
Europ J Gastroenterol Hepatol 1993,5, suppl 2,s70-s72
158) Lazzaroni M, BianchiPorro G: Il trattamento dell'ulcera peptica nell'anziano
Farmaci 1993,17, n 1/2
159) BianchiPorro G, Lazzaroni M: Ulcer healing with drugs that do no affect acid
Practical gastroenterology 1993, 12, S40-S48
160) Lazzaroni M, Petrillo M, Desideri S, BianchiPorro G: Efficacy and tolerability of poliethylene
glycol-electrolyte lavage solution with and without simethicone in the preparation of patients with
inflammatory bowel disease for colonoscopy
Aliment Pharmacol Ther 1993;7,655-659
161) Lazzaroni M, BianchiPorro G. pancreatiti
Enciclopedia Medica Italiana, Uses ed, 1993,5676-5685
162) Lazzaroni M, BianchiPorro G: Guida al paziente ulceroso difficile
medico e paziente,1993;4:40-47
ANNO 1994
163) BianchiPorro G, Lazzaroni M: Approaches to the treatment of Helicobacter pylori infection. In:
Gasbarrini G, Pretolani S: Basic and clinical aspects of helicobacter pylori infection, Springer Verlag,
Berlin, 1994, 298-306
164) Lazzaroni M, BianchiPorro G: Preparation, premedication and surveillance in gastrointestinal
endoscopy
Endoscopy 1994, 26, 3-8
165) Lazzaroni M e Gruppo Italiano per lo studio di Pantoprazolo: Efficacia e tollerabilità di
pantoprazolo vs omeprazolo nell'ulcera duodenale.
Arg Gastroenterol Clin, 1994, 7, 271-275
166) Solcia E, Villani L, Fiocca R, Luinetti O, Boldorini R, Trespi E, Perego M, Alvisi C, Lazzaroni M,
BianchiPorro G:
Effects of eradication of Helicobacter pylori on gastritis in duodenal ulcer patients
Scand J gastroenterol 1994;29 suppl 201:28-34
167) BianchiPorro G, Corinaldesi R, lazzaroni M et al: Long term treatment with omeprazole 20 mg
three days a week or 10 mg daily in the prevention of dudoenal ulcer relapse
Aliment Pharmacol Ther 1994,8:541-548
168) BianchiPorro G, Freston W, Lazzaroni M: The long term management of peptic ucler disease.
Analysis of approaches and reccomedations. In: Proton pump inhibitors and acid related
desorders. Hunt R ed, ADIS, 1994;121-140
ANNO 1995
169) Lazzaroni M, Maconi G, Bargiggia S et al: Efficacy of omeprazole combined with antibiotics for
Helicobacter pylori eradication and dudoenal ulcer recurrence
Eur J Gastroenterol Hepatol 1995;7:117-119
170) Lazzaroni M, Canali A, BianchiPorro G: Double blind, randomized trial of roxatidine 150 mg in
the early evening versus bedtime administration in the short term treatment of duodenal ulcer
Aliment Pharmacol Ther 1995; 9:425-431
171) Solcia E, Villani L, Fiocca R, Luinetti O, Boldorini R, Trespi E, Perego M, Alvisi C, Lazzaroni M,
BianchiPorro G:
Evolution of gastroduodenitis after H pylori eradication
Scand J gastroenterol 1995, 29, suppl 201, 28-34
172) Bassotti G, Mortara G, lazzaroni M et al: Adult Hirschprung disease mimicking Crohn’s disease
Hepatogastroenterology; 42.100-102,1995
ANNO 1996
173) Lazzaroni M, Sangaletti O, Bargiggia S et al: Twenty four hour intragastric acidity following
early evening or bedtime administration of roxatidine in duodenal ulcer patients
Aliment Pharmacol Ther 1996; 10:187-191
174) Lazzaroni M, BianchiPorro G: Preparation, premedication, surveillance
Endoscopy 1996,7:6-12
175) BianchiPorro G, Lazzaroni M, Bargiggia S et al; Omeprazole coupled with two antibiotics for
Helicobacter pylori eraedication and prevention of ulcer recurrence
Am J Gastroenterol 1996; 91;1-6
176) Lazzaroni M, Bargiggia S, sangaletti O et al: Eradication of H pylori and long term outcome of
functional dyspepsia: a clinical endoscopic study
Dig Dis Sci 1996;41:1589-1594
177) Lazzaroni M, BianchiPorro G: Le diarree acute e croniche. In: Aggiornamenti in nutrizione
clinica. Il Pensiero Scientifico Editore, pag 129, 1996
178) Lazzaroni M, BianchiPorro G: Treatment of peptic ulcer in the elderly
Drug &Aging 1996, 4, 251-261
179) BianchiPorro G, lazzaroni M: Terapia medica dell’ulcera peptica. In: Helicobacter pylori e
patologia gastroduodenale. G Ferrini ed, META, Lanciano, 107,1996
ANNO 1997
180) Lazzaroni M, Bargiggia S, BianchiPorro G: Triple therapy with ranitidine or lansoprazole in the
treatment of Helicobacter pylori associated duodenal ulcer
am J gastroenterol 1997;92:1-4
181) BianchiPorro G, LazzaroniM, Petrillo M: Double blind, double dummy, endoscopic comparison
of the mucosal protective effects of misoprostol versus ranitidine on naproxen-induced mucosal
injury to the stomach and duodenum in rheumatic patients
Am J Gastroenterol, 1997;92:663-667
182) Lazzaroni M, BianchiPorro G, Perego M et al: Helicobacter pylori eradication in the healing
and recurrence of benign gastric ulcer: a two year, double blind, placebo controlled study
It J Gastroenter Hepat 1997;29:220-227
183) Scarpignato C, Lazzaroni M, BianchiPorro G: Inibitori selettivi della cicloossigenasi-2: mito o
realtà
Arg Gastroenterol Clin 1997, 6:
ANNO 1998
184) BianchiPorro G, Lazzaroni M. Manzionna G, Petrillo M: Omeprazole and sucralfate in the
treatment of NSAID induced gastric and duodenal ulcers
Aliment Pharmacol Ther, 1998, 12:355-360
185) BianchiPorro, Lazzaroni M, Petrillo M et al: Peptic ulcer therapy with cimetidine cs
tripotassium dicitrato bismutahe (TDB) in rheumatoid arthritis patients undergoin chronic NSAID
treatment
Aliment Pharmacol Ther, 1998, 12:343-347
186) Lazzaroni M, BianchiPorro G: Preparation, premedication and surveillance. Endoscopy, 1998,
30:53-60
187) BianchiPorro G, Lazzaroni M, Petrillo M et al: Prevention of gastroduodenal damage with
omeprazole in patients receiving continous NSAID treatment. A double blind placebo controlled
study
Ital J Gastroenterol Hepatol 1998; 30:43-48
ANNO 1999
188) G BianchiPorro, M Lazzaroni: The conflicting relationship between Helicobacter Pylori and
non-steroidal antiinflammatory drugs in peptic ulcer bleeding
Scand J Gastroenterol, 1999
189) M Lazzaroni, G BianchiPorro: Premedication, preparation, surveillance Endoscopy,1999 31; 28
190) BianchiPorro, Montrone F, Lazzaroni M, caruso I; Clinical and gastroscopic evaluation of
amtolmetin guacyl versus diclofenac in patients with rheumatoid arthritis
It J Gastroenterol Hepatol 1999: 31: 378-385
191) Lazzaroni M, Sainaghi M, BianchiPorro G: Non-steroidal antiinflammatory drug gastropathy:
clinical results with antacids and sucralfate
Ital J Gastroenterol Hepatol 1999: 31, supll 1: 48-53
192) Lazzaroni M, BianchiPorro G: Non-steroidal anti-inflammatory gastropathy: clinical results
with H2 antagonists and proton pump inhibitors
Ital J Gastroenterol Hepatol 1999; 31: suppl 1: 73-78
ANNO 2000
193) BianchiPorro G, Lazzaroni M, Imbesi V, Montrone F, Santagada T: Efficacy of pantoprazole in
the prevention of peptic ulcers, induced by non-steroidal anti-infmattory drugs: a prospective,
ploacebo controlled, double blind, parallel group study
Dig Liv Dis 2000;32: 201-8
194) M Lazzaroni, G Bianchi Porro: Ulcera gastroduodenale
Enciclopedia Medica Italiana: 2000; 3: 6107-6114
195) Lazzaroni M, BianchiPorro G: NSAIDs and upper gastrointestinal injury: update on
pathogenesis, prevention and treatment
Duodenitis & upper GI tract disease, 2000;2:10-16
ANNO 2001
196) Lazzaroni M. Bianchi Porro G: Non-steroidal antiinflammatory drug gastropathy and
Helicobacter pylori: the search for an improbable consensus
Am J Med 2001: 109: 1-5
197) Lazzaroni M, BianchiPorro G: Preparation, premedication, surveillance.
Endoscopy 2001; 33:103-108
198) Lazzaroni M, Anderloni A, BianchiPorro G: The effects on gastroduodenal mucosa of a new
nonsteroidal anti-inflammatory drug, amtometin guacyl, versus piroxicam in heatly volunteers: a
short term, double blind, endoscopically controlled study
Eur J Gastroenterol Hepatol 2001; 13: 833-9
199) M Lazzaroni, G Bianchi Porro: Review article: helicobacter pylori and NSAID gastropathy
Aliment Pharmacol Ther 2001: 15, suppl 1-6
200) Lazzaroni M, Bianchi Porro G.
Prophylaxis and treatment of non-steroidal anti-inflammatory drug-induced upper gastrointestinal
side-effects.
Dig Liver Dis. 2001 Dec;33 Suppl 2:S44-58. Review.
PMID: 11827362 [PubMed - indexed for MEDLINE]
ANNO 2002
201) Lazzaroni M, Petrillo M, Tornaghi R, Massironi E, Sainaghi M, Principi N,Bianchi Porro G.
Upper GI bleeding in healthy full-term infants: a case-control study.
Am J Gastroenterol. 2002 Jan;97(1):89-94.
PMID: 11808975 [PubMed - indexed for MEDLINE]
ANNO 2003
202) Lazzaroni M, Bianchi Porro G.
Preparation, premedication and surveillance.
Endoscopy. 2003 Feb;35(2):103-11. Review.
PMID: 12561003 [PubMed - indexed for MEDLINE]
ANNO 2004
203) Lazzaroni M, Bianchi Porro G.
Gastrointestinal side-effects of traditional non-steroidal anti-inflammatory drugs and new
formulations.
Aliment Pharmacol Ther. 2004 Jul;20 Suppl 2:48-58. Review.
PMID: 15335413 [PubMed - indexed for MEDLINE]
ANNO 2005
204) Parente F, Molteni M, Anderloni A, Lazzaroni M, Bianchi Porro G, Danelli PG, Sampietro G,
Zerbi P. Carcinoid mimicking ileal Crohn's disease.
Gastrointest Endosc. 2005 Jan;61(1):105-6. No abstract available.
PMID: 15672068 [PubMed - indexed for MEDLINE]
205) Lazzaroni M, Bianchi Porro G.
Preparation, premedication, and surveillance.
Endoscopy. 2005 Feb;37(2):101-9. Review.
PMID: 15692924 [PubMed - indexed for MEDLINE]
206) Parente F, Anderloni A, Zerbi P, Lazzaroni M, Sampietro G, Danelli P, Bianchi Porro G.
Intermittent small-bowel obstruction caused by gastric adenocarcinoma in a Meckel's diverticulum.
Gastrointest Endosc. 2005 Jan;61(1):180-3. No abstract available.
PMID: 15672086 [PubMed - indexed for MEDLINE]
207) Lazzaroni M, Casini V, Bianchi Porro G.
Role or carbon dioxide-releasing suppositories in the treatment of chronic functional constipation:
a double-blind, randomised, placebo-controlled trial.
Clin Drug Investig. 2005;25(8):499-505.
ANNO 2007
208) Foschi D, Corsi F, Lazzaroni M, Sangaletti O, Riva P, La Tartara G, Bevilacqua M, Osio M,
Alciati A, Bianchi Porro G, Trabucchi E.
Treatment of morbid obesity by intraparietogastric administration of botulinum toxin: a
randomized, double-blind, controlled study.
Int J Obes (Lond). 2007 Apr;31(4):707-12. Epub 2006 Sep 26.
209) Greco S, Maconi G, Lazzaroni M, Pastore L, Porro GB.
An unsuspected cause of chronic diarrhoea.
Gut. 2007 May;56(5):605, 668. No abstract available.
210) Lazzaroni M, Battocchia A, Bianchi Porro G.
COXIBs and non-selective NSAIDs in the gastroenterological setting: what should patients and
physicians do?
Dig Liver Dis. 2007 Jun;39(6):589-96.
ANNO 2008
211) Lazzaroni M, BianchiPorro G
Management of NSAID-induced Gastrointestinal Toxicity: Focus on Proton Pump Inhibitors
Drugs, 2008, in press
212) Foschi D, Lazzaroni M, Sangaletti O, Corsi F, Trabucchi E, Bianchi Porro G.
Effects of intramural administration of Botulinum Toxin A on gastric emptying and eating capacity
in obese patients.
Dig Liver Dis. 2008 Aug;40(8):667-72.
COLLABORAZIONE A TESTI SCIENTIFICI
Grossi E, Lazzaroni M, Miglioli M: Il carbenoxalone: farmacocinetica e farmacologia clinica. In: La
Malattia Peptica. Barbara L, BianchiPorro G eds, MEDIS, 135-155
Albano O, Barbara L, BianchiPorro G, Biasco G, Borgonovi E, Cheli R, Circella A, DellaMano R,
Lazzaroni M et al: Scelte organizzative e modelli di assistenza: il caso del day hospital
Franco Angeli Editore, 65-102
BianchiPorro G, Petrillo M, Lazzaroni M et al: Healing of duodenal ulcer with twice daily oxmetidine
In: Cimetidine in the 80s, Baron JH ed, Churchill LivingstonEdinburgh, 27-33,1981
BianchiPorro G, petrillo M, lazzaroni M, Sangaletti O The longer term treatment of duodenal
ulceration with cimetidine
In: Peptic ulcer disease: advances in pathogenesis and treatmemt. BianchiPorro G, Bardhan KD
eds, Cortina, 1982, 107-113
Bianchiporro G, Lazzaroni M: Analysis of costs benefits in gastroenterology. In: Progress in Clinical
Pharmacy, Ostino G, Martini N, Van der Klejin eds, Elsevier Biomedical Press, 1982,27
DalMonte PR, D'Imperio N, Giuliani Piccari G, Lazzaroni M et al: Pirenzepine for short and long
term treatment of duodenal ulcer. In: Peptic ulcer disease: advances in pathogenesis and
treatmemt. BianchiPorro G, Bardhan KD eds, Cortina, 1982, 137
Petrillo M, Lazzaroni M, DeNicola C et al: Impiego della ranitidina nella terapia delle lesioni
gastriche e duodenali secondarie a farmaci antiglogistici. Risultati preliminari.
In: ranitidina il nuovo H2 antagonista. Barbara L, Dobrilla G eds, Libreria Cortina, Verona,
1983,169
Mazzacca G, Sabbatini F, Barbara L, Miglioli G, BianchiPorro G, Lazzaroni M et al: Trattamento
dell'ulcera duodenale con ranitidina: studio a lungo termine.
In: ranitidina il nuovo H2 antagonista. Barbara L, Dobrilla G eds, Libreri Cortina, Verona, 1983, 183
Petrillo M, Lazzaroni M, BianchiPorro G: Gli antidiarroici. In: I farmaci delle malattie
gastroenteriche. BianchiPorro G, Tognoni G, Il Pensiero Scientifico, Roma, 1984, 314-319
Lazzaroni M, Prada A, BianchiPorro G: Gli anticolinergici. In.I farmaci delle malattie
gastroenteriche.BianchiPorro G, Tognoni G eds, Il pesnsiero Scientifico, Roma, 67, 1984
BianchiPorro G, Lazzaroni M, Petrillo M: Gli antagonisti dei recettori H2 gastrici ( cimetidina e
ranitidina)
In.I farmaci delle malattie gastroenteriche.
BianchiPorro G, Tognoni G eds, Il pesnsiero Scientifico, Roma, 92, 1984
BianchiPorro G, Lazzaroni M, Parente F: I farmaci della barriera mucosa: il sucralfato In.I farmaci
delle malattie gastroenteriche. BianchiPorro G, Tognoni G eds, Il pesnsiero Scientifico, Roma,
150,1984
Petrillo M, Lazzaroni M, BianchiPorro G: I lassativi
In.I farmaci delle malattie gastroenteriche.
BianchiPorro G, Tognoni G eds, Il pesnsiero Scientifico, Roma, 308, 1984
BianchiPorro G, Grossi E, Sangaletti O, Lazzaroni M et al: Gli antiacidi. In: I farmaci delle malattie
gastroenteriche. BianchiPorro G, Tognoni G eds, Il Pensiero Scientifico, Roma, 38, 1984
Lazzaroni M, Bianchi Porro G: Le prostaglandine. In: I farmaci delle malattie gastroenteriche.
BianchiPorro G, Tognoni G eds, Il Pensiero Scientifico, Roma, 191, 1984
BianchiPorro G, LazzaroniM: Pancreatiti. In:Enciclopedia Medica Italiana, USES Edizioni
Scientifiche, Firenze, 1984:890-911
BianchiPorro G, Lazzaroni M, parente F: Ranitidina, cimetidina, famotidina. In:Enciclopedia Medica
Italiana, USES Edizioni Scientifiche, Firenze, 1984:130-151
DalMonte PR, Giuliani Piccari G, D'Imperio N, BianchiPorro G, Lazzaroni M et al: Pirenzepine for the
treatment of non ulcer dyspepsia: results of a double blind multicentre trial
ExcerptaMedica, Amsterdam, 1985 93-100
Parente F., Lazzaroni M., Panza E.,Ardizzone A., BianchiPorro G.: Sucralfate in the treatment of
duodenal ulcer. A double blind endoscopic controlled short-term study versus placebo.
In: Topics in peptic ulcer disease. Bianchi Porro G., Bardhan KD eds., Cortina International,
1987,169-174.
BianchiPorro G., Lazzaroni M., Parente F., Petrillo M.:
Medical treatment of duodenal ulcer. Presente status.
In: Topics in pepticulcer disease. BianchiPorro G., Bardhan KD eds .Cortina International,3568,1987.
BianchiPorro G., Lazzaroni M., Pagliaro L et al.:
Maintenance treatment with cimetdine in peptic ulcer disease for up to 3 years. Experience in Italy.
In: Topics in peptic ulcer disease. BianchiPorro G., Bardhan KD eds. Cortina International,175180,1987.
Bianchi Porro G, Lazzaroni M: Sucralfate: a new broad
spectrum antiulcer drug ?. In: Treatment of digestive disease with sucralfate. BianchiPorro G.,
Hollander D eds, Cortina International, 13-6,1989
BianchiPorro G, Lazzaroni M: : Terapia dell’ulcera peptica negli anni ’90: tempo di bilanci. Libreria
Cortina, Verona, 1991, pag 176
Lazzaroni M, BianchiPOrro G: Le diarre acute e croniche.In: Aggiornamenti in nutrizione clinica.
Gentile MG ed. Il Pensiero Scientifico Editore, 1992, 129-144
BianchiPorro G, Freston JW, Lazzaroni M: The long term management of peptic ulcer disease. IN:
Proton pumps inhibitors and acid-related disorders.Hunt R ed. ADIS International, Osaka,
1994,121.135
BianchiPorro G, Lazzaroni M: Approaches to the treatment of Helicobacter Pylori infection. In:
Basic and clinical aspects of Helicobacter pylori infection. Gasbarrini G, Pretolani S eds. SpringerVerlag, Berlin, 1994:298-306
Bianchi Porro G, lazzaroni M: Reflusso gastroesofageo ed esofagite. In: Terapia medica
sistematica. Rugarli C ed. Masson, Milano, 293-298
BianchiPorro G, Lazzaroni M: Dispepsia, gastriti, ulcera peptica ed emorragie gastroenteriche. In:
Terapia medica sistematica. Rugarli C ed. Masson, Milano, 299-314
Bianchi Porro G, Lazzaroni M: Malattie del piccolo e grosso intestino. In: Terapia medica
sistematica. Rugarli C ed. Masson, Milano, 315-341
Lazzaroni M, BianchiPorro G: Functional dyspepsia, clinical management. In: Approach to the
patient with chronic gastrointestinal disorders. Corazziare E ed. Messaggi , Milano, 1999, 255-269
BianchiPorro G, Halter F, Lazzaroni M: Peptic ulcer disease. In: Gastroenterology and hepatology.
G BianchiPorro, Cremer M, Krejs G, Ramadori G, Rask-Madsen J eds, McGraw-Hill, London,
1999,167-180
BianchiPorro G, Lazzaroni M: Helicobactder Pylori, infezione da. In: Enciclopedia Medica Italiana,
USES, Firenze, 1999, 2591-2600
Lazzaroni M, BianchiPorro G: Lansoprazolo. In: Enciclopedia Medica Italiana, USES, Firenze, 1999,
3030-33
Lazzaroni M, BianchiPorro G: Omeprazolo. In: Enciclopedia Medica Italiana, USES, Firenze, 1999,
4163-66
Lazzaroni M, BianchiPorro G: Pancreatine. In: Enciclopedia Medica Italiana, USES, Firenze, 1999,
4325-29
Lazzaroni M, BianchiPorro G: Roxatidina. In: Enciclopedia Medica Italiana, USES, Firenze, 2000,
5244-248
BianchiPorro G, Lazzaroni M: Ulcera gastroduodenale In: Enciclopedia Medica Italiana, USES,
Firenze, 2000, 6107-14